- Home
- MRNS
as 01-17-2025 4:00pm EST
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | RADNOR |
| Market Cap: | 29.9M | IPO Year: | 2014 |
| Target Price: | $4.28 | AVG Volume (30 days): | 3.2M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.22 - $10.50 | Next Earning Date: | 03-04-2025 |
| Revenue: | $31,466,000 | Revenue Growth: | 1.63% |
| Revenue Growth (this year): | 14.97% | Revenue Growth (next year): | 57.65% |
Latest Marinus Pharmaceuticals Inc. News
MRNS Breaking Stock News: Dive into MRNS Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
Marinus Pharmaceuticals (MRNS) Upgraded to Buy: Here's What You Should Know
MT Newswires
16 days ago
Truist Reinstates Price Target on Marinus Pharmaceuticals at $0.55, Keeps Hold Rating
TipRanks
19 days ago
Marinus Pharmaceuticals to be acquired by Immedica for 55c per share
Pharmaceutical Technology
19 days ago
Immedica to buy Marinus Pharmaceuticals for $151m
MT Newswires
19 days ago
Sector Update: Health Care Stocks Lower Monday Afternoon
GuruFocus.com
19 days ago
Immedica to Acquire Marinus Pharmaceuticals in $151 Million Deal; Shares Surge 43%
MT Newswires
19 days ago
Sector Update: Health Care
Benzinga
19 days ago
Marinus Pharma Agrees To $151 Million Acquisition By Immedica: Shares Surge Over 40%
Compare MRNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRNS Marinus Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.